Dare Bioscience jumps following receipt of $49M grant from Bill & Melinda Gates Foundation Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Dare Bioscience (DARE) up 53% after entering into an agreement with the Bill & Melinda Gates Foundation, under which the company was awarded a new grant of up to $48.95M to support the development of DARE-LARC1
- Opiant Pharmaceuticals (OPNT) up 33% after announcing top-line results from its confirmatory pharmacokinetic study for OPNT003, nasal nalmefene, for opioid overdose
- America Gold and Silver (USAS) up 6% after reporting that it has signed an agreement with the Mexican Ministries of Economy, Interior and Labor committing to a reopening at the Cosala Operations shut for over 17 months by an illegal blockade
- Immucell (ICCC) up 3% after reporting preliminary Q2 sales results
- Allegheny Technologies (ATI) up 2% after reaching a tentative agreement for its labor contract with the United Steelworkers covering approximately 1,300 represented employees located primarily within the Advanced Alloys & Solutions segment
- OncoSec (ONCS) up 27% after entering into a clinical trial collaboration and supply agreement with Merck (MRK) to evaluate the combination of OncoSec's DNA-plasmid interleukin-12 TAVO with Merck's anti-PD-1 therapy, Keytruda in a global Phase 3 randomized clinical trial
- Sunnova Energy (NOVA) up 4% after Raymond James analyst Pavel Molchanov upgraded shares to Strong Buy from Outperform with an unchanged price target of $50, citing the stock's "irrational" underperformance
UP AFTER EARNINGS -
- MSC Industrial (MSM) up 1%
LOWER -
- Ideaya Biosciences (IDYA) down 11% after announcing that it intends to offer and sell up to $80M of shares of its common stock in an underwritten public offering
- Manhattan Bridge Capital (LOAN) down 13% after filing to sell an undisclosed amount of common stock
Symbols:
DARE USAS ICCC ONCS NOVA MSM IDYA LOAN OPNT Keywords: Fly Intel, Wall Street, Top Stories, Stocks